Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 6
2005 3
2006 6
2007 2
2008 3
2009 2
2010 3
2011 6
2012 4
2013 5
2014 11
2015 4
2016 7
2017 2
2018 7
2019 13
2020 11
2021 6
2022 10
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacoepidemiology and Clinical Correlates of Lithium Treatment for Bipolar Disorder in Asia.
Shuy YK, Santharan S, Chew QH, Lin SK, Ouyang WC, Chen CK, Park SC, Jang OJ, Park JH, Chee KY, Ding KS, Chong J, Zhang L, Li K, Zhu X, Jatchavala C, Pariwatcharakul P, Kallivayalil RA, Grover S, Avasthi A, Ansari M, Maramis MM, Aung PP, Tan CH, Xiang YT, Chong MY, Park YC, Kato TA, Shinfuku N, Baldessarini RJ, Sim K. Shuy YK, et al. Among authors: lin sk. J Clin Psychopharmacol. 2024 Mar-Apr 01;44(2):117-123. doi: 10.1097/JCP.0000000000001813. Epub 2024 Jan 16. J Clin Psychopharmacol. 2024. PMID: 38230861
A brief history of clozapine use in Taiwan.
Lin SK, Lane HY. Lin SK, et al. Schizophr Res. 2023 Jun 29:S0920-9964(23)00224-4. doi: 10.1016/j.schres.2023.06.006. Online ahead of print. Schizophr Res. 2023. PMID: 37391310
Corrigendum to "Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study" [Asian J. Psychiatry 85 (2023) 103613].
Chen CK, Yang SY, Park SC, Jang OJ, Zhu X, Xiang YT, Ouyang WC, Javed A, Sayeed Khan MN, Grover S, Avasthi A, Kallivayalil RA, Chee KY, Chemi N, Kato TA, Hayakawa K, Pariwatcharakul P, Maramis M, Seneviratne L, Sim K, Lin SK. Chen CK, et al. Among authors: lin sk. Asian J Psychiatr. 2023 Nov;89:103650. doi: 10.1016/j.ajp.2023.103650. Epub 2023 Jun 10. Asian J Psychiatr. 2023. PMID: 37308390 No abstract available.
Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study.
Chen CK, Yang SY, Park SC, Jang OJ, Zhu X, Xiang YT, Ouyang WC, Javed A, Khan MNS, Grover S, Avasthi A, Kallivayalil RA, Chee KY, Chemi N, Kato TA, Hayakawa K, Pariwatcharakul P, Maramis M, Seneviratne L, Sim K, Tang WK, Oo T, Sartorius N, Tan CH, Chong MY, Park YC, Shinfuku N, Lin SK. Chen CK, et al. Among authors: lin sk. Asian J Psychiatr. 2023 Jul;85:103613. doi: 10.1016/j.ajp.2023.103613. Epub 2023 Apr 28. Asian J Psychiatr. 2023. PMID: 37163943 Free article.
Clozapine Use for Bipolar Disorder: An Asian Psychotropic Prescription Patterns Consortium Study.
Loo LWJ, Chew QH, Lin SK, Yang SY, Ouyang WC, Chen CK, Park SC, Jang OJ, Park JH, Chee KY, Ding KS, Chong J, Zhang L, Li K, Zhu X, Jatchavala C, Pariwatcharakul P, Kallivayalil RA, Grover S, Avasthi A, Ansari M, Maramis MM, Aung PP, Sartorius N, Xiang YT, Tan CH, Chong MY, Park YC, Kato TA, Shinfuku N, Baldessarini RJ, Sim K. Loo LWJ, et al. Among authors: lin sk. J Clin Psychopharmacol. 2023 May-Jun 01;43(3):278-282. doi: 10.1097/JCP.0000000000001693. J Clin Psychopharmacol. 2023. PMID: 37068038
The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study.
Kubota C, Inada T, Lin SK, Avasthi A, Chee KY, Tanra AJ, Yang SY, Chen LY, Chong MY, Tripathi A, Kallivayalil RA, Grover S, Park SC, Kato TA, Xiang YT, Sim K, Maramis MM, Noor IM, Tan CH, Sartorius N, Shinfuku N. Kubota C, et al. Among authors: lin sk. Hum Psychopharmacol. 2023 Mar;38(2):e2861. doi: 10.1002/hup.2861. Epub 2022 Dec 3. Hum Psychopharmacol. 2023. PMID: 36462184 Clinical Trial.
112 results